RC Capital
RC Capital is a Cincinnati-based healthcare growth equity firm founded in 1994 investing in lower middle market Medical Devices, Healthcare Services, and Healthcare IT companies, currently deploying its sixth fund across two offices.
- Company typePrivate
- Founded1994
- HeadquartersCincinnati, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What RC Capital does
RC Capital (legally River Cities Capital Funds) is a Cincinnati-based healthcare growth equity firm founded in 1994 that invests in commercial-stage companies at the lower end of the US middle market. The firm organizes its investing around three pillars — Medical Devices, Healthcare Services, and Healthcare IT — and positions itself as a sector-specialist operating partner, deploying both financial and human capital alongside portfolio management teams. RC Capital currently manages its sixth fund (Fund VI), maintains a regional office in Raleigh, NC, and runs an 11-50 person team structured into MedTech and Healthcare Services groups under four Managing Partners (Daniel Fleming, J. Carter McNabb, Robert Heimann, and Rurik "Rik" Vandevenne).
The firm does not develop technology products in the conventional sense. Its operating model centers on direct sourcing of proprietary deal flow, majority or significant equity investments in healthcare companies, and value creation through board involvement, executive network access, and operational guidance. Recent disclosed activity includes the $15 million growth financing for Catalyst OrthoScience (October 2025), a growth investment in Captive Radiology (May 2026), a 2022 growth recapitalization of Cognitive Research Corporation (CRC), and an investment in Standard Bariatrics that was realized through its acquisition by Teleflex. The firm also curates ecosystem touchpoints such as the annual Healthcare Operator Summit and the proprietary Senior Management Compensation Survey.
RC Capital's revenue model follows a standard US private equity structure: limited partners commit capital to successive flagship funds, the firm earns management fees on committed or invested capital, and realizes carried interest upon profitable exits. Specific fee rates, fund sizes, AUM, and LPs are not publicly disclosed. The firm's "customers" in effect are two-sided: portfolio companies (which receive capital and operational support) and institutional LPs (family offices, endowments, foundations) that subscribe to the funds. This two-sided structure underwrites the firm's revenue durability and exit-driven economics.
RC Capital firmographics
Firmographics- Name
- RC Capital
- Legal name
- RC Capital (River Cities Capital Funds)
- Website
- https://rccf.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RC Capital is a Cincinnati-based healthcare growth equity firm founded in 1994 investing in lower middle market Medical Devices, Healthcare Services, and Healthcare IT companies, currently deploying its sixth fund across two offices.
- Ownership category
- akta.pro rank
RC Capital industry classification
Industry- Product category
- Healthcare Growth Equity (Private Equity)
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Business Services (B2B) Growth Equity (FSANACAD)
- akta.pro secondary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where RC Capital is headquartered
LocationHeadquarters
- HQ city
- Cincinnati
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
RC Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Portfolio Company Investment Returns: RC Capital generates returns through equity investments in healthcare companies, typically acquiring majority or significant stakes, and realizing returns through portfolio company exits via M&A or recapitalizations. The firm participates as a trusted partner, investing human capital alongside financial capital to drive transformational growth.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Institutional investment management services for Limited Partners |
Distribution channels1 record
Marketing channels4 records
RC Capital product offering
Product offeringCore offering
RC Capital is a healthcare-focused growth equity firm that invests in lower middle market companies across Medical Devices, Healthcare Services, and Healthcare IT. The firm acquires majority or significant equity stakes, then partners with management to drive transformational growth through operational support, strategic guidance, and network access, ultimately realizing returns through M&A exits or recapitalizations.
Product overview
RC Capital is a healthcare-focused growth equity firm, not a product company. The firm does not offer standalone products or services in the traditional sense. Instead, RC Capital builds high-potential healthcare companies by leveraging the interplay of three investment segments: Medical Devices, Healthcare Services, and Healthcare IT. The firm's portfolio includes companies such as SPR Therapeutics, Captive Radiology, Cognitive Research Corporation (CRC), ModifyHealth, Standard Bariatrics, Aligned Cardiovascular Partners, Mindpath Health, FlexCare, and others spanning diagnostic imaging, surgical devices, CNS-focused contract research, food-as-medicine platforms, behavioral health, and healthcare technology solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Devices Growth Equity Investments Growth equity capital and operational partnership for commercial-stage and emerging medical device companies, including surgical devices, diagnostics, and therapeutic technologies. Portfolio examples include Standard Bariatrics and Catalyst OrthoScience.
- Healthcare Services Growth Equity Investments Growth equity capital and value-creation partnership for healthcare services businesses including diagnostic imaging, contract research, cardiovascular care, and food-as-medicine platforms. Portfolio examples include Captive Radiology, Cognitive Research Corporation (CRC), and Aligned Cardiovascular Partners.
- Healthcare IT Growth Equity Investments Growth equity capital and strategic partnership for healthcare information technology companies serving clinicians, payers, and patients, including tech-enabled care delivery, remote patient monitoring, and EMR-connected platforms. Portfolio example includes ModifyHealth.
Quantifiable outcome
- Successful exit of Standard Bariatrics to Teleflex
- +3 more outcomes
Companies that use RC Capital
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
RC Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
RC Capital partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor.
- L.E.K. ConsultingminorL.E.K. Consulting's Stuart Jackson and IIya Trakhtenberg presented insights from their book 'Predictable Winners' at the 2025 Healthcare Operator Summit.
- McKinsey & CompanyminorDr. Jeet Guram from McKinsey led a session on 'State of the Healthcare Market and PE Value Creation' at the 2025 Operator Summit.
- BairdminorBen Port and Jason Porter from Baird's Global Healthcare Investment Banking Group led discussions on M&A environment in healthcare at the 2025 Operator Summit.
- Morgan StanleyminorPeter Harrison from Morgan Stanley led discussions on M&A and capital markets environment in MedTech at the 2025 Operator Summit.
- Reveal HealthTechminorSanchit Mullick and Andrew Bravo from Reveal HealthTech led a session on leveraging AI in portfolio company value creation.
- ghSMART & CompanyminorMichael Haugen from ghSMART presented the ghSMART A Method for hiring top talent at the 2025 Operator Summit dinner.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
RC Capital competitors and assessment
Company assessmentDirect peers
- Webster Equity Partners: Webster Equity Partners is a healthcare-focused growth and buyout firm investing in the lower middle market, with similar deal-size profile and sector emphasis on healthcare services and products — directly comparable to RC Capital's strategy.
- Thyra Capital: Thyra Capital is a healthcare-focused private equity firm targeting growth-stage and lower middle market healthcare companies, overlapping closely with RC Capital's Medical Devices, Healthcare Services, and HCIT focus areas.
- Shore Capital Partners: Shore Capital Partners is a lower middle market private equity firm with a dedicated healthcare practice, investing equity in growth-stage healthcare companies — a close strategic and structural analog to RC Capital.
- Health Velocity Capital: Health Velocity Capital is a healthcare-focused growth equity and venture firm investing across healthcare services, HCIT, and medical devices, making it a closely comparable growth-stage specialist peer.
- AlerisLife (legacy Watermark Capital / Cressey & Company): Cressey & Company is a healthcare-focused PE firm based in Chicago investing in growth-stage healthcare services and technology businesses, similar in strategy and scale to RC Capital.
- Avista Capital Partners: Avista Capital Partners is a healthcare-focused private equity firm investing across healthcare services, pharmaceuticals, and medical devices — a closely comparable sector-specialist peer for benchmarking strategy and portfolio overlap.
Broad incumbents
- Welsh, Carson, Anderson & Stowe (WCAS): WCAS is a large, established healthcare-focused private equity firm with a much broader AUM base but a comparable healthcare services and HCIT investment lens, making it an incumbent reference point for sector-specialist PE.
- New Mountain Capital: New Mountain Capital is a large investment firm with a strong healthcare services and healthcare IT franchise, representing a larger incumbent that competes for many of the same assets RC Capital targets.
- Genstar Capital: Genstar Capital is a diversified PE firm with a meaningful healthcare growth and buyout practice, including medical device and services investing — a relevant broader incumbent in the healthcare lower middle and middle market.
- TPG Capital: TPG operates large healthcare-dedicated funds (TPG Healthcare) investing across services, devices, and life sciences — an incumbent mega-fund whose activities increasingly extend into RC Capital's addressable market.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
RC Capital social profiles
Digital presenceRC Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
RC Capital leadership team
Management profileNumber of profiles
Profiles22 records
RC Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RC Capital M&A and investment
M&A and investmentM&A1 record
Investments117 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RC Capital
What does RC Capital do?
RC Capital is a healthcare-focused growth equity firm that invests in lower middle market companies across Medical Devices, Healthcare Services, and Healthcare IT. The firm acquires majority or significant equity stakes, then partners with management to drive transformational growth through operational support, strategic guidance, and network access, ultimately realizing returns through M&A exits or recapitalizations.
Is RC Capital a public or private company?
RC Capital is a private company. It is classified as management employee owned and is currently operating.
When was RC Capital founded?
RC Capital was founded in 1994. It employs 11 to 50 people.
Where is RC Capital based?
RC Capital is headquartered in Cincinnati, United States, in the North America region.
How does RC Capital make money?
One revenue line is on record: portfolio Company Investment Returns.
Who are RC Capital's main competitors?
Direct peers on record are Webster Equity Partners, Thyra Capital, Shore Capital Partners, Health Velocity Capital, AlerisLife (legacy Watermark Capital / Cressey & Company) and Avista Capital Partners. Broad incumbents are Welsh, Carson, Anderson & Stowe (WCAS), New Mountain Capital, Genstar Capital and TPG Capital.
Does RC Capital have an API?
No public API is recorded for RC Capital.
What industry is RC Capital in?
RC Capital's product category is Healthcare Growth Equity (Private Equity). Its primary akta.pro industry code is FSANACAD, Business Services (B2B) Growth Equity, with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.